BIOMAT Database Logo BIOMAT Database Logo

[Treatment of viral hepatitis with lysozyme]. 1973

V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D005260 Female Females
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Therapeutic and preventive treatment of viral hepatitis with lysozyme].
January 1966, Epatologia (Roma),
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Effectiveness of treatment of viral hepatitis with prednisolone and lysozyme].
June 1978, Klinicheskaia meditsina,
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Behavior of serum isocitrate dehydrogenase in subjects with viral hepatitis after treatment with lysozyme].
January 1966, Epatologia (Roma),
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Lysozyme in the therapy of viral hepatitis].
January 1966, Epatologia (Roma),
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Behavior of serum ornithine-carbamyl-transferase in subjects with viral hepatitis after treatment with lysozyme].
January 1966, Epatologia (Roma),
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Effects of lysozyme treatment on immune reactions in viral hepatitis. Preliminary report].
June 1983, Minerva medica,
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Electrophoretic behavior of serum lipoproteins in subjects with viral hepatitis before and after treatment with lysozyme].
January 1966, Epatologia (Roma),
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Clinical significance of serum lysozyme in viral hepatitis].
June 1977, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Electrophoretic behavior of the serum glycoproteins in subjects with viral hepatitis before and after treatment with lysozyme].
January 1966, Epatologia (Roma),
V P Bubliĭ, and V I Vogdanova, and E A Zadorozhnaia, and L A Panchenko
[Complement and lysozyme levels in the blood of children with viral hepatitis].
May 1986, Pediatriia,
Copied contents to your clipboard!